DIABETES-TREATMENT

DIABETES-TREATMENT

A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating

The End of a LongRunning Shortage Brings Mixed Reactions October 9, 2024 A significant milestone in the medical world was achieved recently with the removal of Mounjaro and Zepbound, two popular glucagonlike peptide 1 (GLP1) medications, from the FDA's drug shortage list..

DIABETES-TREATMENT

Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top

Eli Lilly, the pharmaceutical giant, has become the most valuable pharmaceutical company in the world..